114 related articles for article (PubMed ID: 38347067)
1. Revealing the pharmacological effects of Remodelin against osteosarcoma based on network pharmacology, acRIP-seq and experimental validation.
Gao J; Xu P; Wang F; Zhang W; Min M; Urba R; Fan L
Sci Rep; 2024 Feb; 14(1):3577. PubMed ID: 38347067
[TBL] [Abstract][Full Text] [Related]
2. ac4C acetylation regulates mRNA stability and translation efficiency in osteosarcoma.
Zhang W; Gao J; Fan L; Wang J; He B; Wang Y; Zhang X; Mao H
Heliyon; 2023 Jun; 9(6):e17103. PubMed ID: 37484432
[TBL] [Abstract][Full Text] [Related]
3. Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine Acetylation.
Shrimp JH; Jing Y; Gamage ST; Nelson KM; Han J; Bryson KM; Montgomery DC; Thomas JM; Nance KD; Sharma S; Fox SD; Andressen T; Sinclair WR; Wu H; Allali-Hassani A; Senisterra G; Vedadi M; Lafontaine D; Dahlin JL; Marmorstein R; Walters MA; Meier JL
ACS Med Chem Lett; 2021 Jun; 12(6):887-892. PubMed ID: 34141066
[TBL] [Abstract][Full Text] [Related]
4. Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac
Jin C; Wang T; Zhang D; Yang P; Zhang C; Peng W; Jin K; Wang L; Zhou J; Peng C; Tan Y; Ji J; Chen Z; Sun Q; Yang S; Tang J; Feng Y; Sun Y
J Exp Clin Cancer Res; 2022 Dec; 41(1):345. PubMed ID: 36522719
[TBL] [Abstract][Full Text] [Related]
5. Remodelin, a N-acetyltransferase 10 (NAT10) inhibitor, alters mitochondrial lipid metabolism in cancer cells.
Dalhat MH; Mohammed MRS; Ahmad A; Khan MI; Choudhry H
J Cell Biochem; 2021 Dec; 122(12):1936-1945. PubMed ID: 34605570
[TBL] [Abstract][Full Text] [Related]
6. Remodelin, an inhibitor of NAT10, could suppress hypoxia-induced or constitutional expression of HIFs in cells.
Wu Y; Cao Y; Liu H; Yao M; Ma N; Zhang B
Mol Cell Biochem; 2020 Sep; 472(1-2):19-31. PubMed ID: 32529496
[TBL] [Abstract][Full Text] [Related]
7. Acetylation of Cytidine Residues Boosts HIV-1 Gene Expression by Increasing Viral RNA Stability.
Tsai K; Jaguva Vasudevan AA; Martinez Campos C; Emery A; Swanstrom R; Cullen BR
Cell Host Microbe; 2020 Aug; 28(2):306-312.e6. PubMed ID: 32533923
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology-based research on the effect of Scutellaria baicalensis on osteosarcoma and the underlying mechanism.
Zhang L; Tian Y; Wang J; Deng S; Fan H
Medicine (Baltimore); 2023 Nov; 102(46):e35957. PubMed ID: 37986331
[TBL] [Abstract][Full Text] [Related]
9. Revealing the Potential Markers of N(4)-Acetylcytidine through acRIP-seq in Triple-Negative Breast Cancer.
Zhang X; Zeng J; Wang J; Yang Z; Gao S; Liu H; Li G; Zhang X; Gu Y; Pang D
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553667
[TBL] [Abstract][Full Text] [Related]
10. NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation.
Shi J; Yang C; Zhang J; Zhao K; Li P; Kong C; Wu X; Sun H; Zheng R; Sun W; Chen L; Kong X
Circ Res; 2023 Dec; 133(12):989-1002. PubMed ID: 37955115
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression.
Deng M; Zhang L; Zheng W; Chen J; Du N; Li M; Chen W; Huang Y; Zeng N; Song Y; Chen Y
J Exp Clin Cancer Res; 2023 Jan; 42(1):9. PubMed ID: 36609449
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially expressed genes in the development of osteosarcoma using RNA-seq.
Yang Y; Zhang Y; Qu X; Xia J; Li D; Li X; Wang Y; He Z; Li S; Zhou Y; Xie L; Yang Z
Oncotarget; 2016 Dec; 7(52):87194-87205. PubMed ID: 27888627
[TBL] [Abstract][Full Text] [Related]
13. NAT10 promotes cell proliferation by acetylating
Wei R; Cui X; Min J; Lin Z; Zhou Y; Guo M; An X; Liu H; Janz S; Gu C; Wang H; Yang Y
Acta Pharm Sin B; 2022 Aug; 12(8):3313-3325. PubMed ID: 35967285
[TBL] [Abstract][Full Text] [Related]
14. Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma.
Chen R; Guan Z; Zhong X; Zhang W; Zhang Y
Comput Math Methods Med; 2022; 2022():3197402. PubMed ID: 35069780
[TBL] [Abstract][Full Text] [Related]
15. ac4C acetylation of RUNX2 catalyzed by NAT10 spurs osteogenesis of BMSCs and prevents ovariectomy-induced bone loss.
Yang W; Li HY; Wu YF; Mi RJ; Liu WZ; Shen X; Lu YX; Jiang YH; Ma MJ; Shen HY
Mol Ther Nucleic Acids; 2021 Dec; 26():135-147. PubMed ID: 34513300
[No Abstract] [Full Text] [Related]
16. NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression.
Long Y; Ren Y; Wei Q; Mobet Y; Liu Y; Zhao H; Liu T; Cheng L; Yi P
Int J Med Sci; 2023; 20(8):1079-1090. PubMed ID: 37484809
[TBL] [Abstract][Full Text] [Related]
17. Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy.
Qin G; Bai F; Hu H; Zhang J; Zhan W; Wu Z; Li J; Fu Y; Deng Y
Mol Med; 2024 Jan; 30(1):13. PubMed ID: 38243170
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of N-acetyltransferase 10 using remodelin attenuates doxorubicin resistance by reversing the epithelial-mesenchymal transition in breast cancer.
Wu J; Zhu H; Wu J; Chen W; Guan X
Am J Transl Res; 2018; 10(1):256-264. PubMed ID: 29423010
[TBL] [Abstract][Full Text] [Related]
19. NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC.
Tao W; Tian G; Xu S; Li J; Zhang Z; Li J
Cancer Cell Int; 2021 Aug; 21(1):413. PubMed ID: 34362389
[TBL] [Abstract][Full Text] [Related]
20. Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking.
Liu MY; Jiang DX; Zhao X; Zhang L; Zhang Y; Liu ZD; Liu RZ; Li HJ; Rong XY; Gao YZ
Orthop Surg; 2024 Feb; 16(2):462-470. PubMed ID: 38086608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
